Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioblastoma 18Glioma 11Neoplasms 6Brain Neoplasms 6Astrocytoma 6Neuroblastoma 4Sarcoma, Ewing 3Gliosarcoma 3Sarcoma 2Rhabdomyosarcoma 2Recurrence 2Pancreatic Neoplasms 2Medulloblastoma 2Diffuse Intrinsic Pontine Glioma 2Wilms Tumor 1Spinal Cord Neoplasms 1Rhabdoid Tumor 1Refractory Solid Tumors 1Prostatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Oligodendroglioma 1Neuroendocrine Tumors 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasm Metastasis 1Melanoma, Cutaneous Malignant 1Melanoma 1Lymphoma, Follicular 1Hepatoblastoma 1Ganglioneuroblastoma 1

Interventions

Temozolomide 2ribociclib 1Receptors, Interleukin-8B 1Nivolumab 1Injections 1Everolimus 1Eflornithine 1ACT001 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Diffuse Intrinsic Pontine Glioma × Temozolomide × 30 days × Clear all
NCT06639607 2026-06-03

PRiME II

Washington University School of Medicine

Phase 1/2 Not yet recruiting
68 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Ependymoma, Medulloblastoma, Recurrence

NCT05843253 2026-05-29

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Nationwide Children's Hospital

Phase 2 Recruiting
120 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡